Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Harold Edward Fleming currently holds 17,340 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Harold Edward Fleming has been a net neutral trader of CRSP stock. They have purchased $0 and sold $0 worth of shares.
Harold Edward Fleming's most recent insider trade was on Jun 17, 2026, when they sold 17,340 shares at $0.00 per share.
Harold Edward Fleming serves as Executive at CRISPR Therapeutics AG (CRSP). They have executed 5 insider transactions totaling $0 over their tenure at the company.
Harold Edward Fleming holds the position of Executive at CRISPR Therapeutics AG, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Harold Edward Fleming has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Harold Edward Fleming was on Jun 17, 2026, when they purchased $0 worth of SION shares. This transaction involved 17,340 shares at N/A per share.
Harold Edward Fleming currently owns 17,340 shares of CRISPR Therapeutics AG (CRSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Harold Edward Fleming's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Harold Edward Fleming has 5 Form 4 filings on record as an insider at CRISPR Therapeutics AG.
Set alerts for Harold Edward Fleming and 40,000+ other insiders.